At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $1.05B, above the global median of $566.17M
- PositionPrice-to-book is 0.7×, lower than 95% of its Medical Instruments & Supplies peers (median 2.77×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.25BCNY787.06M · vs all stocks (USD)
Revenue (TTM)
6.98BCNY1.05B · vs all stocks (USD)
Profit Margin
-4.91%vs Medical Instruments & Supplies peers
Beta
0.1590xvs all stocks
52-Week Change
-10.48%vs all stocks
Market Capitalization
5.25BCNY787.06M · vs all stocks (USD)
Enterprise Value
8.63BCNY1.30B · vs all stocks (USD)
Forward P/E
24.71xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.7488xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.6974xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.24xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.11xvs Medical Instruments & Supplies peers
Gross Margin
33.40%vs Medical Instruments & Supplies peers
Profit Margin
-4.91%vs Medical Instruments & Supplies peers
Operating Margin
6.82%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.90%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-2.74%vs Medical Instruments & Supplies peers
Revenue (TTM)
6.98BCNY1.05B · vs all stocks (USD)
Revenue per Share (TTM)
7.05CNYUpdated Nov 19, 2026Quarterly Revenue Growth
27.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.70BCNY254.48M · vs all stocks (USD)
EBITDA (TTM)
382.85MCNY57.42M · vs all stocks (USD)
Net Income (TTM)
-342.64MCNY-51.39M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
40.77%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
935.80MCNY140.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.31BCNY196.55M · vs all stocks (USD)
5-Year Average Dividend Yield
0.71%vs all stocks
Payout Ratio
36.36%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
2.30BCNYFY2025 · Dec 31, 2025Revenue
5.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.84BCNYFY2025 · Dec 31, 2025Gross Profit
899.28MCNYFY2025 · Dec 31, 2025Operating Income
-168.92MCNY-25.34M · vs all stocks (USD)
Pre-tax Income
-661.14MCNYFY2025 · Dec 31, 2025Income Tax Expense
137.28MCNYFY2025 · Dec 31, 2025Net Income
-798.41MCNYFY2025 · Dec 31, 2025EBIT
-389.07MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
382.85MCNYFY2025 · Dec 31, 2025Research & Development
254.42MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
327.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
52.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
24.72MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
272.07MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7600CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
998.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
998.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-798.41MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
39.47MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-419.61MCNYFY2025 · Dec 31, 2025Free Cash Flow
-970.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.62BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-798.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
249.53MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
194.15MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-64.87MCNYFY2025 · Dec 31, 2025Capital Expenditures
-550.41MCNYFY2025 · Dec 31, 2025Net Acquisitions
-228.76MCNYFY2025 · Dec 31, 2025Purchase of Investments
-603.13MCNYFY2025 · Dec 31, 2025Sale of Investments
117.93MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.26BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
878.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-882.84MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-168.38MCNYFY2025 · Dec 31, 2025Other Financing Charges
711.54MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
538.32MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.01BSharesUpdated Nov 19, 2026Float Shares
697.94MSharesUpdated Nov 19, 2026% Held by Insiders
34.45%vs all stocks
% Held by Institutions
1.90%vs all stocks
Total Cash (MRQ)
1.34BCNY201.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.34CNYUpdated Nov 19, 2026Total Debt (MRQ)
2.69BCNY403.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2853xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.9210xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.44CNYUpdated Nov 19, 2026Total Assets
16.76BCNY2.51B · vs all stocks (USD)
Total Current Assets
5.51BCNYFY2025 · Dec 31, 2025Total Liabilities
7.30BCNYFY2025 · Dec 31, 2025Total Non-current Assets
11.26BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
826.79MCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.47BCNYFY2025 · Dec 31, 2025Cash
1.62BCNYFY2025 · Dec 31, 2025Cash Equivalents
80.12MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.70BCNYFY2025 · Dec 31, 2025Other Short-term Investments
934.03MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.08BCNYFY2025 · Dec 31, 2025Inventory
1.13BCNYFY2025 · Dec 31, 2025Accounts Payable
480.45MCNYFY2025 · Dec 31, 2025Short-term Debt
4.54BCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.38MCNYFY2025 · Dec 31, 2025Long-term Debt
626.49MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
14.49MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.01BCNYFY2025 · Dec 31, 2025Retained Earnings
849.20MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.46BCNY1.42B · vs all stocks (USD)
Treasury Stock
30.00MCNYFY2025 · Dec 31, 202552-Week Low
5.00CNYUpdated Nov 19, 202652-Week High
8.91CNYUpdated Nov 19, 202652-Week Change
-10.48%vs all stocks
Beta
0.1590xvs all stocks
50-Day MA
5.92CNYUpdated Nov 19, 2026200-Day MA
6.30CNYUpdated Nov 19, 2026Avg 10-Day Volume
7.91MSharesUpdated Nov 19, 2026Avg 30-Day Volume
16.61MSharesUpdated Nov 19, 2026Diluted EPS (TTM)
-0.3200CNYUpdated Nov 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.7×, lower than 95% of its Medical Instruments & Supplies peers (median 2.77×)Notable
Price-to-book: 0.70Industry median: 2.77Industry P5: 0.95Peers compared: 57.00
Financial Health
Altman Z-Score 0.7: distress zoneCritical
Altman Z-Score: 0.70
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $1.05B, above the global median of $566.17MNotable
Revenue (USD): 1,047,047,120.205Global Median: 566,172,992
Levered free cash flow is $196.55M, above the global median of $18.58MNotable
Levered free cash flow (USD): 196,548,316.705Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Yijiahe Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Zhejiang Grandwall Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jintuo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Hycan Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangzhou Anyka Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou Tronly New Electronic Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangsu Pacific Precision Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aisan Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Great-Sun Foods Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Thyrocare Technologies Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule